All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

This was the stock's second consecutive day of losses.

Day Online Event, 24th March 2025Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "CRS & FATCA Compliance & Reporting (ONLINE EVENT: March 24, 2025)" training course has been added to ResearchAndMarkets.

The stock's fall snapped a three-day winning streak.

President Donald Trump's administration plans to keep fewer than 300 staff at the U.S. Agency for International Development ...

The protest largely focused on the administration's decision to put all directly hired employees of the U.S. agency for ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® DILI assay kit: Human 24.